Research on Resveratrol and Curcumin
Resveratrol and Curcumin are two of the best known natural supplements for healthy aging. A quick search on PubMed yeilds over 8,000 studies with Resveratrol
and nearly 10,000 for Curcumin
. These studies cover a wide range of benefits.
Synergy from combining Resveratrol and Curcumin
Searching again on Pubmed specifies over 100 studies with both Resveratrol and Curcumin as a combination
, with over half published in the last 3 years.
Some of these reviews with quotes from the authors are shown below.
A Systemic Review on the Antioxidant and Anti-inflammatory Effects of Resveratrol, Curcumin and Dietary Nitric Oxide Supplementation on Human Cardiovascular Health
Resveratrol is one of the most studied polyphenols with established cardiovascular benefits
Resveratrol acts directly and indirectly on molecular targets to stimulate endothelial production of nitric oxide (NO), reduce oxidative stress, inhibit vascular inflammation and prevent platelet aggregation
Curcumin has a well-established anti-inflammatory role by regulating numerous transcription factors and cytokines linked to inflammation
Recovery of Bone and Muscle Mass in Patients with Chronic Kidney Disease and Iron Overload on Hemodialysis and Taking Combined Supplementation with Curcumin and Resveratrol
A daily oral dose of 500 mg of Resveratrol and 500 mg of Curcumin resulted in:
A significant difference in Body Mass Index (BMI) values (p = 0.002), fat percentage (p = 0.007), muscle mass (p = 0.01) bone mass (p = 0.01), as well as in the score of the subjective global evaluation (p = 0.03). Also differences were found between the basal and final serum levels of Triglycerides (TG) (p = 0.01), VLDL (p = 0.003)
Demonstrates the beneficial effects of combined supplementation with Curcumin and Resveratrol on muscle and bone mass
Both compounds exert beneficial effect either cooperatively or through differential molecular mechanisms in counteracting aluminum-induced neuroinflammation
A Novel Resveratrol-Curcumin Hybrid, A19, Attenuates High Fat Diet-Induced Nonalcoholic Fatty Liver Disease
A Resveratrol-Curcumin hybrid, has been confirmed to exhibit a good anti-inflammatory activity by preventing LPS-induced inflammatory response in macrophages
Significantly inhibited the HFD-induced lipid accumulation, liver injury, liver inflammation and fibrosis in mouse model
Evaluation of Biophysical as Well as Biochemical Potential of Curcumin and Resveratrol During Prostate Cancer
Curcumin and Resveratrol in Combination Significantly Modulated Biochemical Indices Including Drug-Metabolising Enzymes; Antioxidant Enzymes in DMBA Treated Rats
The study, therefore, concludes that the combination of curcumin and resveratrol holds strong modulatory potential against prostate carcinogenesis
Synergistic Antioxidant Effects of Resveratrol and Curcumin Against Fipronil-Triggered Oxidative Damage in Male Albino Rats
Resveratrol and Curcumin relieved and synergistically reversed the FPN-induced tissue oxidative injury, probably by improving the antioxidant defenses via their free radical scavenging and antioxidant characteristics
Poor Bioavailability of both Resveratrol and Curcumin
Unfortunately, Resveratrol and Curcumin are both poorly absorbed and metabolized in your liver.
When you take a powdered form of Resveratrol or Curcumin - whether in capsule form or otherwise - only a tiny fraction of the active ingredient makes its way to your bloodstream, greatly limiting their effectiveness, and requiring large dosages that may be harmful to the liver.
This 2020 review examined the bioavailability problem:
Nanodelivery of Natural Antioxidants: An Anti-aging Perspective (Lushchak,2020)
According to the authors:
The efficiency of Resveratrol and Curcumin in counteracting various pathological conditions mediated by aging-related oxidative stress and associated chronic inflammation has been repeatedly reported. One important problem is, however, that therapeutic potential of orally administered phytochemicals is substantially restricted because of their low bioavailability than is primarily attributed to their poor water solubility and intestinal permeability.
In particular, the oral bioavailability was found to be about 1–2% for Resveratrol and Curcumin
Liposomal delivery a growing trend to overcome poor bioavailability
Liposomes are microscopic fat-soluble spheres, resembling microscopic cells, with other ingredients trapped inside the water-soluble center ready for delivery.
The nanoliposomal structures in our LSG products—(spheres of fatty acid that encase the Resveratrol and Curcumin)—protect them from the harsh environment of your stomach and digestive tract, allowing the active ingredient to reach the bloodstream intact.
This 2020 review looked at the bioavailability problem with oral delivery of many commonly studied supplements, and the use of nano particles as a solution.
Nanodelivery of phytobioactive compounds for treating aging-associated disorders (Vaiserman, 2020)
Anti-aging properties including antioxidant, anti-inflammatory, anti-tumor, and cardioprotective activities have been reported for various phytobioactive compounds (PBCs) including resveratrol, quercetin, curcumin, catechin, etc. However, the therapeutic potential of orally administered PBCs is limited by their poor stability, bioavailability, and solubility in the gastrointestinal tract.
PBC-loaded nanoparticles designed for oral administration provide many benefits over conventional formulations, including enhanced stability and solubility, prolonged half-life, improved epithelium permeability and bioavailability, enhanced tissue targeting, and minimized side effects.
Research on Liposomal delivery for Resveratrol and Curcumin
Below are some recent studies on the synergistic effects of combining Resveratrol and Curcumin in liposomal delivery.
Curcumin and Resveratrol as Promising Natural Remedies With Nanomedicine Approach
According to authors of this study:
"Coencapsulation of Resveratrol and Curcumin in lipid core nanocapsules have been shown to improve their antiproliferative apoptotic effects."
"Both compounds exhibit similarity in features considering their molecular topography which supports the hypothesis that the targets for absorption may be shared between them and replace each other’s uptake when used in combination."
Liposome Co-Encapsulation as a Strategy for the Delivery of Curcumin and Resveratrol (Zhang, 2019)
This 2019 study found:
In this study, liposomal nanoencapsulation was developed as a strategy to overcome these limitations and improve the antioxidant effects of these compounds.
Liposomes co-encapsulating curcumin and resveratrol presented a lower particle size, lower polydispersity index and greater encapsulation efficiency.
Additionally, liposomes loading both curcumin and resveratrol displayed a higher ability during preparation, storage, heating and surfactant shock than those loaded with individual polyphenol
Liposomal Curcumin & Resveratrol capsules 10-20x more bioavailable in circulation and prostate tissue vs standard capsules
Liposome encapsulation of curcumin and resveratrol in combination reduces prostate incidence in PTEN knockout mice
In this study, we determined the bioavailability of liposome encapsulated Curcumin and Resveratrol, individually and in combination and evaluated the inhibitory effects of these agents against prostate growth and progression
Serum and prostate tissue samples harvested at different time points of 30 min to12 hr with plain liposome (0.1%), Curcumin (50 mg/kg/bw), lipo-curcumin (50 mg/kg/bw), lipo-resveratrol (50 mg/kg/bw) and lipo-curcumin co administered with lipo-resveratrol (25 mg/kg/bw for each)
- Levels of Curcumin and Resveratrol recorded in the serum
- Levels of Curcumin and Resveratrol recorded in the prostate
- Quantification of tumor growth inhibition. Total number of adenocarcinomas observed under 10 high-power fields of control vs. treatment groups.
Curcumin and Resveratrol are natural compounds whose strong antioxidant activities are highly beneficial in the human diet.
Unfortunately, their physicochemical properties result in poor stability in their chemical and antioxidant activities, which limits their utilization in food and pharmaceutical applications.
Liposomal nanoencapsulation was developed as a strategy to overcome these limitations and improve the bioavailability of these compounds.